IGM Biosciences, Inc.

NASDAQ:IGMS

1.39 (USD) • At close March 11, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20242023202220212020201920182017
Revenue 2.6792.131.06900000
Cost of Revenue 08.27710.6027.7243.5762.3330.2780.161
Gross Profit 2.679-6.147-9.533-7.724-3.576-2.333-0.278-0.161
Gross Profit Ratio 1-2.886-8.91800000
Reseach & Development Expenses 160.854215.519179.289127.02665.0335.25718.9628.639
General & Administrative Expenses 50.40550.07249.73638.29718.259.2413.8292.508
Selling & Marketing Expenses 00000000
SG&A 50.40550.07249.73638.29718.259.2413.8292.508
Other Expenses 00-0.1810.1591.9251.3650.080.093
Operating Expenses 211.259265.591229.025165.32383.2844.49822.79111.147
Operating Income -208.58-263.461-227.956-165.323-83.28-44.498-22.791-11.147
Operating Income Ratio -77.857-123.691-213.24200000
Total Other Income Expenses Net 12.78517.7236.8540.1591.9251.3650.080.093
Income Before Tax -195.795-245.738-221.102-165.164-81.355-43.133-22.711-11.054
Income Before Tax Ratio -73.085-115.37-206.83100000
Income Tax Expense 00.678-6.854-4.484-1.025-0.5970.080
Net Income -195.795-246.416-214.248-160.68-80.33-42.536-22.711-11.054
Net Income Ratio -73.085-115.688-200.41900000
EPS -3.24-4.71-5.16-4.8-2.61-4.73-51.84-25.24
EPS Diluted -3.24-4.71-5.16-4.8-2.61-4.73-51.84-25.24
EBITDA -208.58-253.358-221.881-157.44-77.779-40.8-22.513-10.986
EBITDA Ratio -77.857-118.947-213.24200000